Table 2.

Overall frequency of antimicrobial resistant E. coli from community-onset vs healthcare-onset/associated bacteriuria episodes, 2014–2020

	Number of antimicrobial resistant E. coli bacteriuria episodes, n (%)
	NIT	T/S	CIP	ESBL	Any AMR	MDR
Community onset*	129 (2)	2691 (35)	1537 (20)	623 (8)	4719 (61)	1306 (16.85)
Healthcare onset/associated**	42 (3)	544 (43)	496 (39)	308 (24)	911 (71)	401 (31.30)

Data from a public healthcare system including inpatient and outpatient services and a skilled nursing facility; NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance. Not all ESBL-E. coli samples were tested for NIT, T/S or CIP

^*7751 isolates tested for ESBL, Any AMR, or MDR, 7737 for T/S and CIP, 7736 tested for NIT

^**1277 isolates tested for ESBL, Any AMR, or MDR, 1274 for T/S and CIP, 1273 for NIT